Authors :
Varsini S.R
Volume/Issue :
Volume 7 - 2022, Issue 6 - June
Google Scholar :
https://bit.ly/3IIfn9N
Scribd :
https://bit.ly/3uCjFex
DOI :
https://doi.org/10.5281/zenodo.6812559
Abstract :
The vaxzevria is a vaccine for preventing covid19 caused by SARS-CoV-2 virus in people from the age of
18 years and older. Also known as Astra-Zeneca or
(ChAdOx1 S [recombinant]). The vaccine is 63% effective
in an ongoing, large-scale clinical trial. The vaccine has been
modified to induce either of mRNA COVID-19 vaccines
(Pfizer or Moderna). They can be used as a second dose in
cases where Astra Zeneca was given as the first dose.
Though the vaccine has been approved in nearly 138
countries, a total of 184,679 cases of side effects were
reported. The vaccine has reported to prevent over 50
million COVID-19 cases. The vaccine is taken as 2 doses
plus a booster dose of injections.
Keywords :
Astra-Zeneca; AZD1222; Covid -19; Delta Variant; Side Effects; TTS
The vaxzevria is a vaccine for preventing covid19 caused by SARS-CoV-2 virus in people from the age of
18 years and older. Also known as Astra-Zeneca or
(ChAdOx1 S [recombinant]). The vaccine is 63% effective
in an ongoing, large-scale clinical trial. The vaccine has been
modified to induce either of mRNA COVID-19 vaccines
(Pfizer or Moderna). They can be used as a second dose in
cases where Astra Zeneca was given as the first dose.
Though the vaccine has been approved in nearly 138
countries, a total of 184,679 cases of side effects were
reported. The vaccine has reported to prevent over 50
million COVID-19 cases. The vaccine is taken as 2 doses
plus a booster dose of injections.
Keywords :
Astra-Zeneca; AZD1222; Covid -19; Delta Variant; Side Effects; TTS
